Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.
Yemaachi Biotech is at the forefront of cancer innovation, leveraging Africa's diverse genetic landscape to develop next-generation cancer drugs that are effective across various populations. Our mission is to transform lives through inclusive, innovative science.
Yemaachi Biotech offers tailored solutions and services. For detailed pricing information, please contact our sales team.
Yemaachi Biotech boasts an unmatched global team with African roots, comprising scientists, engineers, and business operators. Our team is dedicated to building a global biotech company that leverages African genetic diversity to improve cancer treatment outcomes worldwide.
Cancer tests based on whole genome and transcriptome data.
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
PipeBio is a SaaS bioinformatics platform to develop antibody drugs.
Personalized drug discovery for blood cancer.
Adventris makes cancer vaccines
Personalized prevention using genetics and AI
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS